Ping Yuan

2.8k total citations
130 papers, 1.7k citations indexed

About

Ping Yuan is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Ping Yuan has authored 130 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pulmonary and Respiratory Medicine, 44 papers in Cardiology and Cardiovascular Medicine and 26 papers in Molecular Biology. Recurrent topics in Ping Yuan's work include Pulmonary Hypertension Research and Treatments (73 papers), Cardiovascular Function and Risk Factors (21 papers) and Liver Disease and Transplantation (10 papers). Ping Yuan is often cited by papers focused on Pulmonary Hypertension Research and Treatments (73 papers), Cardiovascular Function and Risk Factors (21 papers) and Liver Disease and Transplantation (10 papers). Ping Yuan collaborates with scholars based in China, United States and Canada. Ping Yuan's co-authors include Zhi‐Cheng Jing, Lan Wang, Qin‐Hua Zhao, Wenhui Wu, Xin Jiang, Rong Jiang, Bigyan Pudasaini, Jinming Liu, Jing He and Rui Zhang and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Ping Yuan

125 papers receiving 1.7k citations

Peers

Ping Yuan
Ling Zhou China
Rajesh Gupta United States
Ling Sun China
Saran Shantikumar United Kingdom
Changchuan Jiang United States
Lei Zhao China
Bo Ding Sweden
Pensée Wu United Kingdom
Ling Zhou China
Ping Yuan
Citations per year, relative to Ping Yuan Ping Yuan (= 1×) peers Ling Zhou

Countries citing papers authored by Ping Yuan

Since Specialization
Citations

This map shows the geographic impact of Ping Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Yuan more than expected).

Fields of papers citing papers by Ping Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Yuan. The network helps show where Ping Yuan may publish in the future.

Co-authorship network of co-authors of Ping Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Yuan. A scholar is included among the top collaborators of Ping Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Yuan. Ping Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Ping, et al.. (2025). From Homeostasis To Inflammation To Autoimmunity: The Potential Impact of CRP. Inflammation. 48(6). 3747–3762.
2.
Zhao, Qin‐Hua, Rui Zhang, Shao‐Fei Liu, et al.. (2025). Phenotypic Analysis of Pulmonary Hypertension Associated With Low Diffusion Capacity and Preserved Lung Function. Pulmonary Circulation. 15(4). e70210–e70210.
3.
Kou, Jie‐Jian, Hongda Zhang, Xinmei Xie, et al.. (2024). Metabolic alterations in human pulmonary artery smooth muscle cells treated with PDGFBB. SHILAP Revista de lepidopterología. 8(7). 1268–1276. 1 indexed citations
4.
Zhou, Guangyuan, Yunpeng Wei, Ting Zhang, et al.. (2024). Identification of Noncoding Functional Regulatory Variants of STIM1 Gene in Idiopathic Pulmonary Arterial Hypertension. Hypertension. 81(9). 1895–1909. 1 indexed citations
5.
Huang, Jincheng, et al.. (2024). Correction of congenital auricle deformities with ear mould: A systematic review and meta-analysis. International Journal of Pediatric Otorhinolaryngology. 179. 111903–111903.
6.
Hu, Xiaoyi, Yuanyuan Sun, Shang Wang, et al.. (2024). CircALMS1 Alleviates Pulmonary Microvascular Endothelial Cell Dysfunction in Pulmonary Hypertension. Journal of the American Heart Association. 13(6). e031867–e031867. 3 indexed citations
7.
Yuan, Ping, Jun Chen, Shang Wang, et al.. (2024). Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension. Clinical Cardiology. 47(2). 1 indexed citations
8.
Hu, Xiaoyi, Shang Wang, Hui Zhao, et al.. (2023). CircPMS1 promotes proliferation of pulmonary artery smooth muscle cells, pulmonary microvascular endothelial cells, and pericytes under hypoxia. SHILAP Revista de lepidopterología. 7(3). 310–323. 4 indexed citations
9.
Zhao, Hui, Bill Kalionis, Xiaoyi Hu, et al.. (2023). The Impact of Abnormal Lipid Metabolism on the Occurrence Risk of Idiopathic Pulmonary Arterial Hypertension. International Journal of Molecular Sciences. 24(18). 14280–14280. 4 indexed citations
10.
Wang, Lan, Yi Yan, Jing He, et al.. (2023). Identification of the shared gene signatures between pulmonary fibrosis and pulmonary hypertension using bioinformatics analysis. Frontiers in Immunology. 14. 1197752–1197752. 3 indexed citations
11.
Yan, Yi, Shang Wang, Ping Yuan, et al.. (2023). Retrospective on global pulmonary hypertension clinical trials: 1999–2021. Journal of Thoracic Disease. 15(6). 3372–3385. 3 indexed citations
12.
Sun, Yuanyuan, Wenhui Wu, Qin‐Hua Zhao, et al.. (2022). CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension. Frontiers in Cell and Developmental Biology. 10. 967708–967708. 7 indexed citations
13.
Wei, Yunpeng, Xiaoyuan Liu, Lu Wang, et al.. (2022). Calcium Sensing Receptor Variants Increase Pulmonary Hypertension Susceptibility. Hypertension. 79(7). 1348–1360. 8 indexed citations
15.
Wang, Lan, Li Shen, Bigyan Pudasaini, et al.. (2021). Survival in severe pulmonary hypertension due to chronic lung disease: influence of in‐hospital platelet distribution width. Pulmonary Circulation. 11(3). 1–7. 2 indexed citations
17.
Zhu, Li, Qiang Hao, Feng Tian, et al.. (2021). Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension. Circulation. 143(18). 1775–1792. 24 indexed citations
18.
Wu, Wenhui, Ping Yuan, Rong Jiang, et al.. (2021). Liver dysfunction in idiopathic pulmonary arterial hypertension: prevalence, characteristics and prognostic significance, a retrospective cohort study in China. BMJ Open. 11(9). e045165–e045165. 3 indexed citations
19.
Wang, Yiming, Min Xia, Nan Shan, et al.. (2017). Pregabalin can decrease acute pain and postoperative nausea and vomiting in hysterectomy. Medicine. 96(31). e7714–e7714. 13 indexed citations
20.
Yuan, Ping. (2004). Application of bilirubin adsorption with HB-H-6 resin plasma perfusion in preoperative for pancreatic cancer with severe obstructive jaundice. Zhonghua gan-dan waike zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026